
Immunotherapy [85]


Antibody-based anti-tumor immunotherapy
Pierre Bruhns

A synthetic glycopeptide for anti-tumor immunotherapy: from design to first use in human
Sylvie Bay

Clinical development of cancer vaccines
Claude Leclerc

Regulation of innate CD8 memory T cells during Salmonella typhimurium infection.
Sylvie Garcia

Guilherme Dias de Melo
Trypanosomatids Infectious Processes
Guilherme Dias de Melo is veterinarian. He obtained his degree in Veterinary Medicine (december 2010), his MD in Veterinary Sciences (june 2012) and his PhD in Veterinary Sciences (june 2015) at the Sao Paulo […]

The role of a gradient of the chemokine CXCL12 in hematopoietic development and in a normal immune response. (Collaboration with F. Arenzana-Seisdedos, granted ANR funding)
Paulo Vieira

ERC-2010-StG LymphocyteContacts
Philippe Bousso

ANR TranSig – Trans-signalling: A novel mechanism of Leishmania host cell immune evasion through the release of parasite signalling proteins
Najma Rachidi

PTR 539 – A multilevel systems approach to elucidate the host-Leishmania interactome and to identify host targets for anti-leishmanial drug discovery
Joo Hwan No

PTR 496 – Investigating the reciprocal relationship between macrophage inflammasome activity and intracellular Leishmania infection
Eric Prina

Matthieu Rousseau
I done my PhD studies in Dr Eric Boilard’s laboratory (Québec, Canada) from September 2010 to March 2015. Since September 2015, I started postdoctoral studies in the laboratory of Dr Matthew Albert, in the […]

Role of CD8 T cells responses in the control of HIV-2 infection-ANRS Immunovir2
Asier Sáez-Cirión

USE OF ANTl-FcyRI AND/OR ANTl-FcyRllA ANTIBODIES FOR TREATING ARTHRITIS, INFLAMMATION, THROMBOCYTOPENIA AND ALLERGIC SHOCK
Pierre Bruhns

Clinical Operation Coordination Office
Nathalie Jolly
